Skip to content

Validation of the Utility of Strabismus Intelligent Diagnostic System

Validation of the Utility of Strabismus Intelligent Diagnostic System: A Clinical Trial

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04416776
Enrollment
323
Registered
2020-06-04
Start date
2019-09-01
Completion date
2020-06-10
Last updated
2020-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ophthalmological Disorder, Strabismus

Brief summary

Strabismus affects approximately 0.8%-6.8% of the world's population and appears by the age of 3 years in 65% of affected individuals. Manual measurement of deviation is often laborious and highly dependent on the experience of the specialist and the cooperation of the patients. Current strabismus evaluation technologies are heavily dependent on model eyes. Here, the investigators use deep learning to develop an artificial intelligence (AI) platform consisting of three deep learning (DL) systems to screen strabismus, evaluate deviation and propose a surgical plan based on corneal light-reflection photos. The investigator also conduct clinical trial to validate its versatility in clinical practice.

Interventions

DRUGStrabismus diagnostic system.

An AI platform based on corneal light-reflection photos to facilitate the diagnosis and angle evaluation of strabismus and to provide advice for surgical planning.

Sponsors

Sun Yat-sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients in the outpatient clinic of strabismus department.

Exclusion criteria

* Patients or their parents diagree to participate in the trial. * Patients with blepharoptosis. * Patients can't facing forward or lacking fixation.

Design outcomes

Primary

MeasureTime frame
The proportion of accurate, mistaken and miss detection of the diagnostic system.up to 3 years

Countries

China

Contacts

Primary ContactKeli Mao, M.D
maokl@mail2.sysu.edu.cn87330493

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026